RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 162 filers reported holding RELAY THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $22 | -12.0% | 3,355 | +9.2% | 0.00% | – |
| Q1 2024 | $25 | -72.2% | 3,072 | -62.5% | 0.00% | -100.0% |
| Q4 2023 | $90 | +16.9% | 8,201 | -10.0% | 0.00% | 0.0% |
| Q3 2023 | $77 | -28.0% | 9,115 | +6.5% | 0.00% | 0.0% |
| Q2 2023 | $107 | -29.6% | 8,557 | -7.1% | 0.00% | 0.0% |
| Q1 2023 | $152 | -10.1% | 9,208 | -18.7% | 0.00% | -50.0% |
| Q4 2022 | $169 | -99.9% | 11,322 | +13.4% | 0.00% | 0.0% |
| Q3 2022 | $223,000 | +34.3% | 9,986 | +1.0% | 0.00% | 0.0% |
| Q2 2022 | $166,000 | -50.0% | 9,884 | -10.9% | 0.00% | -33.3% |
| Q1 2022 | $332,000 | -54.6% | 11,087 | -53.5% | 0.00% | 0.0% |
| Q4 2021 | $732,000 | +123.9% | 23,830 | +130.0% | 0.00% | 0.0% |
| Q3 2021 | $327,000 | -16.8% | 10,361 | -3.6% | 0.00% | 0.0% |
| Q2 2021 | $393,000 | +93.6% | 10,749 | +82.7% | 0.00% | -62.5% |
| Q1 2021 | $203,000 | – | 5,882 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 5,998,574 | $75,342,089 | 6.58% |
| Nextech Invest Ltd. | 948,659 | $11,915,157 | 4.05% |
| MPM BioImpact LLC | 1,354,368 | $17,010,862 | 3.42% |
| Finepoint Capital LP | 701,570 | $8,811,719 | 3.05% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $350,486,335 | 2.67% |
| EcoR1 Capital, LLC | 4,163,824 | $52,297,629 | 1.28% |
| BVF INC/IL | 3,120,521 | $39,193,744 | 1.09% |
| Integral Health Asset Management, LLC | 700,000 | $8,792,000 | 1.09% |
| Boxer Capital, LLC | 1,819,132 | $22,848 | 1.06% |
| Alphabet Inc. | 1,568,753 | $19,703,537 | 1.06% |